Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.13 Million USD | -7.65% |
| 2022 | 7.73 Million USD | 68.53% |
| 2021 | 4.58 Million USD | -4.01% |
| 2020 | 4.77 Million USD | 6.74% |
| 2019 | 4.47 Million USD | 134.51% |
| 2018 | 1.9 Million USD | 23.06% |
| 2017 | 1.55 Million USD | 0.76% |
| 2016 | 1.53 Million USD | 16.65% |
| 2015 | 1.31 Million USD | 125.14% |
| 2014 | 586.23 Thousand USD | -29.42% |
| 2013 | 830.57 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.05 Million USD | 12.56% |
| 2024 Q3 | 1.54 Million USD | -24.84% |
| 2024 Q2 | 2.05 Million USD | -0.37% |
| 2023 Q2 | 1.62 Million USD | -26.45% |
| 2023 FY | 7.13 Million USD | -7.65% |
| 2023 Q4 | 1.82 Million USD | 188.71% |
| 2023 Q3 | 633.37 Thousand USD | -61.05% |
| 2023 Q1 | 2.21 Million USD | -14.66% |
| 2022 Q4 | 2.59 Million USD | 43.65% |
| 2022 Q1 | 1.62 Million USD | 17.49% |
| 2022 Q2 | 1.71 Million USD | 5.81% |
| 2022 Q3 | 1.8 Million USD | 5.18% |
| 2022 FY | 7.73 Million USD | 68.53% |
| 2021 Q3 | 1.06 Million USD | -12.98% |
| 2021 FY | 4.58 Million USD | -4.01% |
| 2021 Q4 | 1.37 Million USD | 29.1% |
| 2021 Q1 | 911.03 Thousand USD | -32.36% |
| 2021 Q2 | 1.22 Million USD | 34.77% |
| 2020 Q2 | 1.11 Million USD | -11.01% |
| 2020 Q1 | 1.25 Million USD | -22.73% |
| 2020 FY | 4.77 Million USD | 6.74% |
| 2020 Q4 | 1.34 Million USD | 27.14% |
| 2020 Q3 | 1.05 Million USD | -5.16% |
| 2019 Q1 | 771.96 Thousand USD | 35.96% |
| 2019 FY | 4.47 Million USD | 134.51% |
| 2019 Q4 | 1.62 Million USD | 74.13% |
| 2019 Q3 | 932.92 Thousand USD | -18.69% |
| 2019 Q2 | 1.14 Million USD | 48.63% |
| 2018 Q4 | 567.77 Thousand USD | 19.19% |
| 2018 Q3 | 476.35 Thousand USD | 6.44% |
| 2018 Q2 | 447.51 Thousand USD | 7.24% |
| 2018 Q1 | 417.32 Thousand USD | 16.17% |
| 2018 FY | 1.9 Million USD | 23.06% |
| 2017 FY | 1.55 Million USD | 0.76% |
| 2017 Q4 | 359.23 Thousand USD | -4.3% |
| 2017 Q3 | 375.36 Thousand USD | 16.4% |
| 2017 Q2 | 322.48 Thousand USD | -34.74% |
| 2017 Q1 | 494.18 Thousand USD | 18.31% |
| 2016 Q1 | 402.82 Thousand USD | -24.84% |
| 2016 FY | 1.53 Million USD | 16.65% |
| 2016 Q4 | 417.71 Thousand USD | 27.05% |
| 2016 Q3 | 328.78 Thousand USD | -15.76% |
| 2016 Q2 | 390.3 Thousand USD | -3.11% |
| 2015 Q4 | 535.93 Thousand USD | 237.57% |
| 2015 FY | 1.31 Million USD | 125.14% |
| 2015 Q1 | 269.25 Thousand USD | 66.07% |
| 2015 Q2 | 355.88 Thousand USD | 32.18% |
| 2015 Q3 | 158.76 Thousand USD | -55.39% |
| 2014 Q1 | 61.77 Thousand USD | -70.25% |
| 2014 Q3 | 340.19 Thousand USD | 1437.12% |
| 2014 Q4 | 162.12 Thousand USD | -52.34% |
| 2014 FY | 586.23 Thousand USD | -29.42% |
| 2014 Q2 | 22.13 Thousand USD | -64.17% |
| 2013 Q4 | 207.64 Thousand USD | 0.0% |
| 2013 FY | 830.57 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 36.397% |
| Cerus Corporation | 143.15 Million USD | 95.013% |
| OrthoPediatrics Corp. | 137.01 Million USD | 94.79% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 37.163% |
| Talis Biomedical Corporation | 67.18 Million USD | 89.375% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 71.383% |
| Inogen, Inc. | 236.08 Million USD | 96.976% |
| Spectral AI, Inc. | 20.86 Million USD | 65.784% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 87.251% |
| CVRx, Inc. | 76.14 Million USD | 90.624% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -102.347% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 42.839% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.93% |
| Venus Concept Inc. | 80.47 Million USD | 91.129% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 87.382% |
| Bioventus Inc. | 409.91 Million USD | 98.258% |
| BrainsWay Ltd. | 28.01 Million USD | 74.521% |
| Envoy Medical, Inc. | 17.89 Million USD | 60.114% |
| electroCore, Inc. | 32.03 Million USD | 77.713% |
| IceCure Medical Ltd | 16.87 Million USD | 57.698% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 83.176% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 59.515% |
| MaxCyte, Inc. | 84.84 Million USD | 91.586% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 42.484% |
| Nexalin Technology, Inc. | 5.78 Million USD | -23.48% |
| PAVmed Inc | 64.82 Million USD | 88.988% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 86.024% |
| RxSight, Inc. | 103.85 Million USD | 93.126% |
| Sight Sciences, Inc. | 126.44 Million USD | 94.354% |
| SI-BONE, Inc. | 156.35 Million USD | 95.434% |
| TELA Bio, Inc. | 84.18 Million USD | 91.52% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 89.81% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 96.49% |
| LivaNova PLC | 843.54 Million USD | 99.154% |
| 908 Devices Inc. | 68.08 Million USD | 89.514% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.524% |
| NeuroPace, Inc. | 75.29 Million USD | 90.519% |
| LENSAR, Inc. | 33.33 Million USD | 78.585% |
| Apyx Medical Corporation | 51.01 Million USD | 86.007% |
| Cutera, Inc. | 197.72 Million USD | 96.39% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 71.192% |
| BioSig Technologies, Inc. | 28.53 Million USD | 74.978% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 96.272% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 80.203% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 99.146% |
| Axonics, Inc. | 270.2 Million USD | 97.358% |
| Outset Medical, Inc. | 198.77 Million USD | 96.409% |
| IRIDEX Corporation | 31.81 Million USD | 77.561% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 96.039% |
| IRadimed Corporation | 30.12 Million USD | 76.301% |
| Tivic Health Systems, Inc. | 8.53 Million USD | 16.329% |
| INVO Bioscience, Inc. | 7.85 Million USD | 9.098% |
| Telesis Bio, Inc. | 63.48 Million USD | 88.756% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 92.749% |
| Varex Imaging Corporation | 224.8 Million USD | 96.824% |
| Quipt Home Medical Corp. | 148.66 Million USD | 95.198% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 39.104% |
| Pulmonx Corporation | 112.68 Million USD | 93.665% |
| Dynatronics Corporation | 9.9 Million USD | 27.949% |
| Modular Medical, Inc. | 17.52 Million USD | 59.274% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 64.637% |
| Semler Scientific, Inc. | 38.94 Million USD | 81.669% |
| InMode Ltd. | 215.68 Million USD | 96.69% |
| Bruker Corporation | 1.07 Billion USD | 99.337% |
| Cytosorbents Corporation | 48.33 Million USD | 85.231% |
| DexCom, Inc. | 1.69 Billion USD | 99.578% |
| Align Technology, Inc. | 2.07 Billion USD | 99.656% |
| Viveve Medical, Inc. | 22.17 Million USD | 67.804% |
| ZimVie Inc. | 275.12 Million USD | 97.405% |
| Movano Inc. | 29.69 Million USD | 75.956% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 94.799% |
| Nexalin Technology, Inc. | 5.78 Million USD | -23.48% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -102.347% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.812% |
| Profound Medical Corp. | 33.6 Million USD | 78.756% |
| Insulet Corporation | 939.9 Million USD | 99.24% |
| enVVeno Medical Corporation | 25.23 Million USD | 71.714% |
| Surmodics, Inc. | 98.69 Million USD | 92.767% |
| iCAD, Inc. | 22.22 Million USD | 67.879% |
| Nuwellis, Inc. | 22.61 Million USD | 68.431% |
| Biotricity, Inc. | 17.18 Million USD | 58.458% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.399% |
| Aethlon Medical, Inc. | 12.27 Million USD | 41.855% |
| InspireMD, Inc. | 22.95 Million USD | 68.894% |
| PAVmed Inc. | 64.82 Million USD | 88.988% |
| BIOLASE, Inc. | 34.66 Million USD | 79.404% |
| Beyond Air, Inc. | 61.7 Million USD | 88.43% |
| FONAR Corporation | 28.6 Million USD | 75.043% |
| AxoGen, Inc. | 149.33 Million USD | 95.22% |
| Vivani Medical, Inc. | 26.96 Million USD | 73.526% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 95.969% |
| Inari Medical, Inc. | 448.59 Million USD | 98.409% |
| UFP Technologies, Inc. | 58.08 Million USD | 87.711% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -44.874% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -12.986% |
| Tenon Medical, Inc. | 16.96 Million USD | 57.928% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | 3.438% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 83.813% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.338% |
| Sintx Technologies, Inc. | 15.2 Million USD | 53.037% |
| NanoVibronix, Inc. | 4.97 Million USD | -43.551% |
| Quanterix Corporation | 118.1 Million USD | 93.955% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 39.104% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 50.569% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 98.182% |
| TransMedics Group, Inc. | 182.82 Million USD | 96.095% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 74.563% |
| NeuroMetrix, Inc. | 11.09 Million USD | 35.68% |
| Hyperfine, Inc. | 52.87 Million USD | 86.498% |
| Establishment Labs Holdings Inc. | 172 Million USD | 95.85% |
| Biomerica, Inc. | 6.97 Million USD | -2.304% |
| Bone Biologics Corporation | 9.42 Million USD | 24.283% |
| AVITA Medical, Inc. | 80.77 Million USD | 91.163% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 30.767% |
| Silk Road Medical, Inc | 186.35 Million USD | 96.169% |